1422431-55-7

Basic information

• Product Name: (S)-2-benzyloxy-3,9,10-trimethoxytetrahydroprotoberberine
• Synonyms: (S)-2-benzyloxy-3,9,10-trimethoxytetrahydroprotoberberine
• CAS NO: 1422431-55-7
• Molecular Weight: 431.532
• Mol File: 1422431-55-7.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (S)-2-benzyloxy-3,9,10-trimethoxytetrahydroprotoberberine(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-2-benzyloxy-3,9,10-trimethoxytetrahydroprotoberberine(1422431-55-7)
• EPA Substance Registry System: (S)-2-benzyloxy-3,9,10-trimethoxytetrahydroprotoberberine(1422431-55-7)

Safety Data

• Hazardous Substances Data: 1422431-55-7(Hazardous Substances Data)

Upstream product

• 77-78-1 dimethyl sulfate 
• 63909-38-6 3-methoxy-4-benzyloxy-ω-nitrostyrolene 
• 1429118-77-3 (S)-(6-((7-(benzyloxy)-6-methoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl)-2,3-dimethoxyphenyl)methanol 
• 1422431-47-7 (S)-6-((7-(benzyloxy)-6-methoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl)-2,3-dimethoxybenzyl acetate 
• 1422431-39-7 6-((7-(benzyloxy)-6-methoxy-3,4-dihydroisoquinolin-1-yl)methyl)-2,3-dimethoxybenzyl acetate 
• 1422431-32-0 6-(2-(4-(benzyloxy)-3-methoxyphenethylamino)-2-oxoethyl)-2,3-dimethoxybenzyl acetate 
• 2426-87-1 3-methoxy-4-(phenylmethoxy)benzaldehyde 
• 1422431-28-4 N-(4-(benzyloxy)-3-methoxyphenethyl)-2-(2-(hydroxymethyl)-3,4-dimethoxyphenyl)acetamide 
• 4697-59-0 7,8-dimethoxyisochroman-3-one 
• 56201-87-7 8-hydroxy-7-methoxyisobenzofuranyltetrahydropyran-3-one 
• 1131-94-8 homoisovanillic acid 
• 100-39-0 benzyl bromide 
• 121-33-5 vanillin 
• 19626-36-9 methyl 2-(3-bromo-4-methoxyphenyl)acetate 

Downstream Products

• 6487-33-8 (-)-isocorypalmine 

Relevant articles and documents

TETRAHYDROPROTOBERBERINE COMPOUND, PREPARATION METHOD THEREFOR AND USES THEREOF, AND PHARMACEUTICAL COMPOSITION

The present invention provides a tetrahydroprotoberberine compound represented by the formula (I), enantiomers, diastereomers, racemates and mixtures thereof, and pharmaceutically acceptable salts, crystalline hydrates and solvates thereof. The invention also provides a method for preparing the compound and the use thereof in the preparation of a medicament for preventing and/or treating central nervous system diseases.